These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24466111)

  • 1. Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.
    Salazar L; Kashiwada T; Krejci P; Meyer AN; Casale M; Hallowell M; Wilcox WR; Donoghue DJ; Thompson LM
    PLoS One; 2014; 9(1):e86470. PubMed ID: 24466111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
    Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
    Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.
    Qing J; Du X; Chen Y; Chan P; Li H; Wu P; Marsters S; Stawicki S; Tien J; Totpal K; Ross S; Stinson S; Dornan D; French D; Wang QR; Stephan JP; Wu Y; Wiesmann C; Ashkenazi A
    J Clin Invest; 2009 May; 119(5):1216-29. PubMed ID: 19381019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
    Yao F; Zhou W; Zhong C; Fang W
    Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.
    Prickett TD; Ninomiya-Tsuji J; Broglie P; Muratore-Schroeder TL; Shabanowitz J; Hunt DF; Brautigan DL
    J Biol Chem; 2008 Jul; 283(28):19245-54. PubMed ID: 18456659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.
    Wi SM; Moon G; Kim J; Kim ST; Shim JH; Chun E; Lee KY
    J Biol Chem; 2014 Dec; 289(51):35205-14. PubMed ID: 25371197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
    Shin MS; Shinghirunnusorn P; Sugishima Y; Nishimura M; Suzuki S; Koizumi K; Saiki I; Sakurai H
    Biochim Biophys Acta; 2009 Jul; 1793(7):1156-64. PubMed ID: 19393267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.
    Plowright EE; Li Z; Bergsagel PL; Chesi M; Barber DL; Branch DR; Hawley RG; Stewart AK
    Blood; 2000 Feb; 95(3):992-8. PubMed ID: 10648414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
    Kobayashi T; Kuroda J; Ashihara E; Oomizu S; Terui Y; Taniyama A; Adachi S; Takagi T; Yamamoto M; Sasaki N; Horiike S; Hatake K; Yamauchi A; Hirashima M; Taniwaki M
    Leukemia; 2010 Apr; 24(4):843-50. PubMed ID: 20200560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.
    Drafahl KA; McAndrew CW; Meyer AN; Haas M; Donoghue DJ
    PLoS One; 2010 Dec; 5(12):e14412. PubMed ID: 21203561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
    Gingery A; Bradley EW; Pederson L; Ruan M; Horwood NJ; Oursler MJ
    Exp Cell Res; 2008 Sep; 314(15):2725-38. PubMed ID: 18586026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.
    Thiefes A; Wolter S; Mushinski JF; Hoffmann E; Dittrich-Breiholz O; Graue N; Dörrie A; Schneider H; Wirth D; Luckow B; Resch K; Kracht M
    J Biol Chem; 2005 Jul; 280(30):27728-41. PubMed ID: 15837794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1.
    Kumar M; Makonchuk DY; Li H; Mittal A; Kumar A
    J Immunol; 2009 Feb; 182(4):2439-48. PubMed ID: 19201899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
    Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
    J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression.
    Yu Y; Ge N; Xie M; Sun W; Burlingame S; Pass AK; Nuchtern JG; Zhang D; Fu S; Schneider MD; Fan J; Yang J
    J Biol Chem; 2008 Sep; 283(36):24497-505. PubMed ID: 18617512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.
    Meyer AN; McAndrew CW; Donoghue DJ
    Cancer Res; 2008 Sep; 68(18):7362-70. PubMed ID: 18794123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation.
    Meyer AN; Gastwirt RF; Schlaepfer DD; Donoghue DJ
    J Biol Chem; 2004 Jul; 279(27):28450-7. PubMed ID: 15105428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
    Kang J; Chung KC
    Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
    Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.